Advertisement
Research Article

Preclinical Assessment of HIV Vaccines and Microbicides by Repeated Low-Dose Virus Challenges

  • Roland R Regoes mail,

    To whom correspondence should be addressed. E-mail: rregoes@emory.edu

    Affiliation: Department of Biology, Emory University, Atlanta, Georgia, United States of America

    X
  • Ira M Longini Jr,

    Affiliation: Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America

    X
  • Mark B Feinberg,

    Affiliations: Departments of Medicine and Microbiology and Immunology, Emory University School of Medicine and the Emory Vaccine Center, Atlanta, Georgia, United States of America, Merck Vaccine Division, Merck, West Point, Pennsylvania, United States of America

    X
  • Silvija I Staprans

    Affiliation: Departments of Medicine and Microbiology and Immunology, Emory University School of Medicine and the Emory Vaccine Center, Atlanta, Georgia, United States of America

    X
  • Published: July 19, 2005
  • DOI: 10.1371/journal.pmed.0020249

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Modeling HIV Vaccine Strategy in Animals

Synopsis | published 19 Jul 2005 | PLOS Medicine
doi:10.1371/journal.pmed.0020258